[1]
W. A. Hewedy, E. I. Anwar, G. M. Sharara, M. A. Hadi, S. A. Darwish, and C. A. Ismail, “Oncogenic challenge of bromocriptine and L-arginine versus conventional antidiabetics on diethyl nitrosamine-induced liver tumorigenesis in diabetic rats: focus on AMPK activation”, Int J Basic Clin Pharmacol, vol. 12, no. 1, pp. 1–9, Dec. 2022.